ArticlePLOS digital health2026
The adaptive large language models for vaccine prediction: A novel approach to vaccine demand prediction with engineered deviation prompts.
Article in PLOS digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate vaccine demand forecasting is crucial for minimizing wastage and ensuring efficient immunization programs. In this study, we introduce an Adaptive Large Language Model for Vaccine Prediction (ALLMVP) that integrates large language model (LLM) architectures with an adaptive value correction mechanism. Using vaccination record data from Xuhui District, Shanghai, China (2014-2022), we conducted a comparative analysis of ALLMVP against seven other models, including standard machine learning methods (logistic regression, random forest, Long Short-Term Memory) and their enhanced versions with the same adaptive value correction mechanism. Our findings indicate that traditional models encountered significant challenges in attaining high predictive accuracy, while frameworks based on LLMs markedly enhanced their forecasting capabilities. Notably, ALLMVP achieved an acceptance ratio of 71.43%, which is considerably superior to that of the other models under consideration. Yearly and cumulative evaluations across seven vaccines from the National Immunization Program demonstrated that ALLMVP consistently delivered more precise estimates, aligning closely with actual vaccine demand even under challenging conditions, such as the post-COVID era. These results highlight the potential of adaptive LLM-driven forecasting tools to fullfill stringent prediction accuracy standards set by governments and to aid in data-informed vaccination strategizing. The AI infrastructure underpinning ALLMVP holds the promise of being generalized and deployed across a range of forecasting applications and at a significantly larger scale.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.